Article
Case-control study of the association between select HLA genes and anti-erythropoietin antibody-positive pure red-cell aplasia.
Pharmacogenomics - 1 Feb 2008
Fijal Bonnie, Ricci Deborah, Vercammen Els, Palmer Peter A, Fotiou Fotis, Fife Daniel, Lindholm Anders, Broderick Erin, Francke Stephan, Wu Xiaodong, Colaianne James, Cohen Nadine
Abstract excerpt
AIMS: Antibody (Ab)-positive pure red-cell aplasia (PRCA) is a very rare but serious adverse event associated with recombinant human erythropoietin treatment (4.1 reports per 100,000 patient-years) in which patients produce antibodies to recombinant and endogenous erythropoietin, halting red blood cell production. In a previous case series, four Thai subjects with chronic kidney disease and Ab-positive PRCA were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
